Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Liquidia Technologies, Inc.
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH
October 13, 2026
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
September 30, 2026
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud’s Phenomenon Associated with Systemic Sclerosis
September 3, 2026
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
September 2, 2026
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
September 1, 2026
Liquidia Corporation Reports Second Quarter 2026 Financial Results
August 20, 2026
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
August 18, 2026
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
May 27, 2026
Liquidia Corporation Reports First Quarter 2026 Financial Results
May 11, 2026
Liquidia Corporation to Participate in Upcoming Investor Conferences
May 6, 2026
1
2
Next Page
→